APO Research

APO RESEARCH · REPORT

Irreversible Hydrocolloid

Selected research

Industry Growth & Trends

Global Irreversible Hydrocolloid Industry Growth and Trends Forecast to 2032

Market perspective

The global Irreversible Hydrocolloid market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Irreversible Hydrocolloid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Irreversible Hydrocolloid is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Irreversible Hydrocolloid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Irreversible Hydrocolloid include Zhermack, Ultradent Products, Septodont, Monitex Industrial, Lascod, Kulzer, Kerr, Ivoclar and Hygedent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Irreversible Hydrocolloid market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Irreversible Hydrocolloid market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Irreversible Hydrocolloid market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Irreversible Hydrocolloid.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Irreversible Hydrocolloid market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Irreversible Hydrocolloid Market by Company

Zhermack

Ultradent Products

Septodont

Monitex Industrial

Lascod

Kulzer

Kerr

Ivoclar

Hygedent

Hager & Werken

GC Corporation

Elsodent

DUX Dental

Dentsply Sirona

Dentamerica

Cavex

Irreversible Hydrocolloid Segment by Type

Regular-set Type

Fast-set Type

Irreversible Hydrocolloid Segment by Application

Dental Clinics

Dental Education

Others

Irreversible Hydrocolloid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Irreversible Hydrocolloid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Irreversible Hydrocolloid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Irreversible Hydrocolloid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Irreversible Hydrocolloid manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Irreversible Hydrocolloid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Regular-set Type Table 2. Major Company of Fast-set Type Table 3. Global Irreversible Hydrocolloid Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Irreversible Hydrocolloid Sales by Type (2021-2026) & (t) Table 5. Global Irreversible Hydrocolloid Sales Market Share in Volume by Type (2021-2026) Table 6. Global Irreversible Hydrocolloid Sales by Type (2021-2026) & (US$ Million) Table 7. Global Irreversible Hydrocolloid Sales Market Share in Value by Type (2021-2026) Table 8. Global Irreversible Hydrocolloid Price by Type (2021-2026) & (USD/t) Table 9. Global Irreversible Hydrocolloid Sales by Type (2027-2032) & (t) Table 10. Global Irreversible Hydrocolloid Sales Market Share in Volume by Type (2027-2032) Table 11. Global Irreversible Hydrocolloid Sales by Type (2027-2032) & (US$ Million) Table 12. Global Irreversible Hydrocolloid Sales Market Share in Value by Type (2027-2032) Table 13. Global Irreversible Hydrocolloid Price by Type (2027-2032) & (USD/t) Table 14. North America Irreversible Hydrocolloid Sales by Type (2021-2026) & (t) Table 15. North America Irreversible Hydrocolloid Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Irreversible Hydrocolloid Sales by Type (2021-2026) & (t) Table 17. Europe Irreversible Hydrocolloid Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Irreversible Hydrocolloid Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Irreversible Hydrocolloid Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Irreversible Hydrocolloid Sales by Type (2021-2026) & (t) Table 21. Latin America Irreversible Hydrocolloid Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Irreversible Hydrocolloid Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Irreversible Hydrocolloid Sales by Type (2021-2026) & (US$ Million) Table 24. Irreversible Hydrocolloid Industry Trends Table 25. Irreversible Hydrocolloid Industry Drivers Table 26. Irreversible Hydrocolloid Industry Opportunities and Challenges Table 27. Irreversible Hydrocolloid Industry Restraints Table 28. Global Irreversible Hydrocolloid Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Irreversible Hydrocolloid Revenue Market Share by Company (2021-2026) Table 30. Global Irreversible Hydrocolloid Sales by Company (2021-2026) & (t) Table 31. Global Irreversible Hydrocolloid Sales Share by Company (2021-2026) Table 32. Global Irreversible Hydrocolloid Market Price by Company (2021-2026) & (USD/t) Table 33. Global Irreversible Hydrocolloid Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Irreversible Hydrocolloid Major Company Production Sites and Headquarters Table 35. Global Irreversible Hydrocolloid Company, Product Type & Application Table 36. Global Irreversible Hydrocolloid Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Irreversible Hydrocolloid by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Irreversible Hydrocolloid Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Irreversible Hydrocolloid Sales by Region (2021-2026) & (t) Table 41. Global Irreversible Hydrocolloid Sales Market Share in Volume by Region (2021-2026) Table 42. Global Irreversible Hydrocolloid Sales by Region (2021-2026) & (US$ Million) Table 43. Global Irreversible Hydrocolloid Sales Market Share in Value by Region (2021-2026) Table 44. Global Irreversible Hydrocolloid Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Global Irreversible Hydrocolloid Sales by Region (2027-2032) & (t) Table 46. Global Irreversible Hydrocolloid Sales Market Share in Volume by Region (2027-2032) Table 47. Global Irreversible Hydrocolloid Sales by Region (2027-2032) & (US$ Million) Table 48. Global Irreversible Hydrocolloid Sales Market Share in Value by Region (2027-2032) Table 49. Global Irreversible Hydrocolloid Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 50. Global Irreversible Hydrocolloid Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Irreversible Hydrocolloid Sales by Application (2021-2026) & (t) Table 52. Global Irreversible Hydrocolloid Sales Market Share in Volume by Application (2021-2026) Table 53. Global Irreversible Hydrocolloid Sales by Application (2021-2026) & (US$ Million) Table 54. Global Irreversible Hydrocolloid Sales Market Share in Value by Application (2021-2026) Table 55. Global Irreversible Hydrocolloid Price by Application (2021-2026) & (USD/t) Table 56. Global Irreversible Hydrocolloid Sales by Application (2027-2032) & (t) Table 57. Global Irreversible Hydrocolloid Sales Market Share in Volume by Application (2027-2032) Table 58. Global Irreversible Hydrocolloid Sales by Application (2027-2032) & (US$ Million) Table 59. Global Irreversible Hydrocolloid Sales Market Share in Value by Application (2027-2032) Table 60. Global Irreversible Hydrocolloid Price by Application (2027-2032) & (USD/t) Table 61. North America Irreversible Hydrocolloid Sales by Application (2021-2026) & (t) Table 62. North America Irreversible Hydrocolloid Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Irreversible Hydrocolloid Sales by Application (2021-2026) & (t) Table 64. Europe Irreversible Hydrocolloid Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Irreversible Hydrocolloid Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Irreversible Hydrocolloid Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Irreversible Hydrocolloid Sales by Application (2021-2026) & (t) Table 68. Latin America Irreversible Hydrocolloid Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Irreversible Hydrocolloid Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Irreversible Hydrocolloid Sales by Application (2021-2026) & (US$ Million) Table 71. Zhermack Company Information Table 72. Zhermack Business Overview Table 73. Zhermack Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Zhermack Irreversible Hydrocolloid Product Portfolio Table 75. Zhermack Recent Development Table 76. Ultradent Products Company Information Table 77. Ultradent Products Business Overview Table 78. Ultradent Products Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Ultradent Products Irreversible Hydrocolloid Product Portfolio Table 80. Ultradent Products Recent Development Table 81. Septodont Company Information Table 82. Septodont Business Overview Table 83. Septodont Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Septodont Irreversible Hydrocolloid Product Portfolio Table 85. Septodont Recent Development Table 86. Monitex Industrial Company Information Table 87. Monitex Industrial Business Overview Table 88. Monitex Industrial Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Monitex Industrial Irreversible Hydrocolloid Product Portfolio Table 90. Monitex Industrial Recent Development Table 91. Lascod Company Information Table 92. Lascod Business Overview Table 93. Lascod Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Lascod Irreversible Hydrocolloid Product Portfolio Table 95. Lascod Recent Development Table 96. Kulzer Company Information Table 97. Kulzer Business Overview Table 98. Kulzer Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. Kulzer Irreversible Hydrocolloid Product Portfolio Table 100. Kulzer Recent Development Table 101. Kerr Company Information Table 102. Kerr Business Overview Table 103. Kerr Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Kerr Irreversible Hydrocolloid Product Portfolio Table 105. Kerr Recent Development Table 106. Ivoclar Company Information Table 107. Ivoclar Business Overview Table 108. Ivoclar Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Ivoclar Irreversible Hydrocolloid Product Portfolio Table 110. Ivoclar Recent Development Table 111. Hygedent Company Information Table 112. Hygedent Business Overview Table 113. Hygedent Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Hygedent Irreversible Hydrocolloid Product Portfolio Table 115. Hygedent Recent Development Table 116. Hager & Werken Company Information Table 117. Hager & Werken Business Overview Table 118. Hager & Werken Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Hager & Werken Irreversible Hydrocolloid Product Portfolio Table 120. Hager & Werken Recent Development Table 121. GC Corporation Company Information Table 122. GC Corporation Business Overview Table 123. GC Corporation Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. GC Corporation Irreversible Hydrocolloid Product Portfolio Table 125. GC Corporation Recent Development Table 126. Elsodent Company Information Table 127. Elsodent Business Overview Table 128. Elsodent Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 129. Elsodent Irreversible Hydrocolloid Product Portfolio Table 130. Elsodent Recent Development Table 131. DUX Dental Company Information Table 132. DUX Dental Business Overview Table 133. DUX Dental Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 134. DUX Dental Irreversible Hydrocolloid Product Portfolio Table 135. DUX Dental Recent Development Table 136. Dentsply Sirona Company Information Table 137. Dentsply Sirona Business Overview Table 138. Dentsply Sirona Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 139. Dentsply Sirona Irreversible Hydrocolloid Product Portfolio Table 140. Dentsply Sirona Recent Development Table 141. Dentamerica Company Information Table 142. Dentamerica Business Overview Table 143. Dentamerica Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 144. Dentamerica Irreversible Hydrocolloid Product Portfolio Table 145. Dentamerica Recent Development Table 146. Cavex Company Information Table 147. Cavex Business Overview Table 148. Cavex Irreversible Hydrocolloid Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 149. Cavex Irreversible Hydrocolloid Product Portfolio Table 150. Cavex Recent Development Table 151. North America Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 152. North America Irreversible Hydrocolloid Sales by Country (2021-2026) & (t) Table 153. North America Irreversible Hydrocolloid Sales Market Share by Country (2021-2026) Table 154. North America Irreversible Hydrocolloid Sales Forecast by Country (2027-2032) & (t) Table 155. North America Irreversible Hydrocolloid Sales Market Share Forecast by Country (2027-2032) Table 156. North America Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. North America Irreversible Hydrocolloid Market Size by Country (2021-2026) & (US$ Million) Table 158. North America Irreversible Hydrocolloid Market Share by Country (2021-2026) Table 159. North America Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. North America Irreversible Hydrocolloid Market Share Forecast by Country (2027-2032) Table 161. Europe Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 162. Europe Irreversible Hydrocolloid Sales by Country (2021-2026) & (t) Table 163. Europe Irreversible Hydrocolloid Sales Market Share by Country (2021-2026) Table 164. Europe Irreversible Hydrocolloid Sales Forecast by Country (2027-2032) & (t) Table 165. Europe Irreversible Hydrocolloid Sales Market Share Forecast by Country (2027-2032) Table 166. Europe Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Europe Irreversible Hydrocolloid Market Size by Country (2021-2026) & (US$ Million) Table 168. Europe Irreversible Hydrocolloid Market Share by Country (2021-2026) Table 169. Europe Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Europe Irreversible Hydrocolloid Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Irreversible Hydrocolloid Sales by Country (2021-2026) & (t) Table 173. Asia-Pacific Irreversible Hydrocolloid Sales Market Share by Country (2021-2026) Table 174. Asia-Pacific Irreversible Hydrocolloid Sales Forecast by Country (2027-2032) & (t) Table 175. Asia-Pacific Irreversible Hydrocolloid Sales Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Irreversible Hydrocolloid Market Size by Country (2021-2026) & (US$ Million) Table 178. Asia-Pacific Irreversible Hydrocolloid Market Share by Country (2021-2026) Table 179. Asia-Pacific Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Asia-Pacific Irreversible Hydrocolloid Market Share Forecast by Country (2027-2032) Table 181. Latin America Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 182. Latin America Irreversible Hydrocolloid Sales by Country (2021-2026) & (t) Table 183. Latin America Irreversible Hydrocolloid Sales Market Share by Country (2021-2026) Table 184. Latin America Irreversible Hydrocolloid Sales Forecast by Country (2027-2032) & (t) Table 185. Latin America Irreversible Hydrocolloid Sales Market Share Forecast by Country (2027-2032) Table 186. Latin America Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Latin America Irreversible Hydrocolloid Market Size by Country (2021-2026) & (US$ Million) Table 188. Latin America Irreversible Hydrocolloid Market Share by Country (2021-2026) Table 189. Latin America Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Latin America Irreversible Hydrocolloid Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Irreversible Hydrocolloid Sales by Country (2021-2026) & (t) Table 193. Middle East and Africa Irreversible Hydrocolloid Sales Market Share by Country (2021-2026) Table 194. Middle East and Africa Irreversible Hydrocolloid Sales Forecast by Country (2027-2032) & (t) Table 195. Middle East and Africa Irreversible Hydrocolloid Sales Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Irreversible Hydrocolloid Market Size by Country (2021-2026) & (US$ Million) Table 198. Middle East and Africa Irreversible Hydrocolloid Market Share by Country (2021-2026) Table 199. Middle East and Africa Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Middle East and Africa Irreversible Hydrocolloid Market Share Forecast by Country (2027-2032) Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Irreversible Hydrocolloid Distributors List Table 204. Irreversible Hydrocolloid Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Irreversible Hydrocolloid Image Figure 2. Global Irreversible Hydrocolloid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Irreversible Hydrocolloid Market Size (2021-2032) & (US$ Million) Figure 4. Global Irreversible Hydrocolloid Sales (2021-2032) & (t) Figure 5. Regular-set Type Image Figure 6. Global Regular-set Type Sales YoY Growth (2021-2032) & (t) Figure 7. Fast-set Type Image Figure 8. Global Fast-set Type Sales YoY Growth (2021-2032) & (t) Figure 9. Global Irreversible Hydrocolloid Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Irreversible Hydrocolloid Market Share by Type 2025 VS 2032 Figure 11. North America Irreversible Hydrocolloid Sales Market Share in Volume by Type in 2025 Figure 12. North America Irreversible Hydrocolloid Sales Market Share in Value by Type in 2025 Figure 13. Europe Irreversible Hydrocolloid Sales Market Share in Volume by Type in 2025 Figure 14. Europe Irreversible Hydrocolloid Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Irreversible Hydrocolloid Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Irreversible Hydrocolloid Sales Market Share in Value by Type in 2025 Figure 17. Latin America Irreversible Hydrocolloid Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Irreversible Hydrocolloid Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Irreversible Hydrocolloid Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Irreversible Hydrocolloid Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Irreversible Hydrocolloid Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Dental Clinics Image Figure 24. Global Dental Clinics Sales YoY Growth (2021-2032) & (t) Figure 25. Dental Education Image Figure 26. Global Dental Education Sales YoY Growth (2021-2032) & (t) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (t) Figure 29. Global Irreversible Hydrocolloid Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Irreversible Hydrocolloid Market Share by Application 2025 VS 2032 Figure 31. North America Irreversible Hydrocolloid Sales Market Share in Volume by Application in 2025 Figure 32. North America Irreversible Hydrocolloid Sales Market Share in Value by Application in 2025 Figure 33. Europe Irreversible Hydrocolloid Sales Market Share in Volume by Application in 2025 Figure 34. Europe Irreversible Hydrocolloid Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Irreversible Hydrocolloid Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Irreversible Hydrocolloid Sales Market Share in Value by Application in 2025 Figure 37. Latin America Irreversible Hydrocolloid Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Irreversible Hydrocolloid Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Irreversible Hydrocolloid Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Irreversible Hydrocolloid Sales Market Share in Value by Application in 2025 Figure 41. North America Irreversible Hydrocolloid Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 42. North America Irreversible Hydrocolloid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Irreversible Hydrocolloid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Irreversible Hydrocolloid Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Irreversible Hydrocolloid Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. Europe Irreversible Hydrocolloid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Irreversible Hydrocolloid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Irreversible Hydrocolloid Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Irreversible Hydrocolloid Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Asia-Pacific Irreversible Hydrocolloid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Irreversible Hydrocolloid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Irreversible Hydrocolloid Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Irreversible Hydrocolloid Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Latin America Irreversible Hydrocolloid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Irreversible Hydrocolloid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Irreversible Hydrocolloid Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Irreversible Hydrocolloid Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Middle East and Africa Irreversible Hydrocolloid Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Irreversible Hydrocolloid Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Irreversible Hydrocolloid Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Irreversible Hydrocolloid Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Irreversible Hydrocolloid Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Regular-set Type
  • Fast-set Type
Applications
  • Dental Clinics
  • Dental Education
  • Others
Companies covered
  • Zhermack
  • Ultradent Products
  • Septodont
  • Monitex Industrial
  • Lascod
  • Kulzer
  • Kerr
  • Ivoclar
  • Hygedent
  • Hager & Werken
  • GC Corporation
  • Elsodent
  • DUX Dental
  • Dentsply Sirona
  • Dentamerica
  • Cavex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Irreversible Hydrocolloid Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Irreversible Hydrocolloid Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Irreversible Hydrocolloid Market by Type
  6. 1.3.1 Regular-set Type
  7. 1.3.2 Fast-set Type
  8. 1.4 Global Irreversible Hydrocolloid Market Size by Type
  9. 1.4.1 Global Irreversible Hydrocolloid Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Irreversible Hydrocolloid Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Irreversible Hydrocolloid Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Irreversible Hydrocolloid Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Irreversible Hydrocolloid Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Irreversible Hydrocolloid Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Irreversible Hydrocolloid Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Irreversible Hydrocolloid Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Irreversible Hydrocolloid Industry Trends
  2. 2.2 Irreversible Hydrocolloid Industry Drivers
  3. 2.3 Irreversible Hydrocolloid Industry Opportunities and Challenges
  4. 2.4 Irreversible Hydrocolloid Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Irreversible Hydrocolloid Revenue (2021-2026)
  2. 3.2 Global Top Players by Irreversible Hydrocolloid Sales (2021-2026)
  3. 3.3 Global Top Players by Irreversible Hydrocolloid Price (2021-2026)
  4. 3.4 Global Irreversible Hydrocolloid Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Irreversible Hydrocolloid Major Company Production Sites & Headquarters
  6. 3.6 Global Irreversible Hydrocolloid Company, Product Type & Application
  7. 3.7 Global Irreversible Hydrocolloid Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Irreversible Hydrocolloid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Irreversible Hydrocolloid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Irreversible Hydrocolloid Tier 1, Tier 2, and Tier 3
4 Irreversible Hydrocolloid Regional Status and Outlook
  1. 4.1 Global Irreversible Hydrocolloid Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Irreversible Hydrocolloid Historic Market Size by Region
  3. 4.2.1 Global Irreversible Hydrocolloid Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Irreversible Hydrocolloid Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Irreversible Hydrocolloid Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Irreversible Hydrocolloid Forecasted Market Size by Region
  7. 4.3.1 Global Irreversible Hydrocolloid Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Irreversible Hydrocolloid Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Irreversible Hydrocolloid Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Irreversible Hydrocolloid by Application
  1. 5.1 Irreversible Hydrocolloid Market by Application
  2. 5.1.1 Dental Clinics
  3. 5.1.2 Dental Education
  4. 5.1.3 Others
  5. 5.2 Global Irreversible Hydrocolloid Market Size by Application
  6. 5.2.1 Global Irreversible Hydrocolloid Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Irreversible Hydrocolloid Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Irreversible Hydrocolloid Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Irreversible Hydrocolloid Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Irreversible Hydrocolloid Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Irreversible Hydrocolloid Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Irreversible Hydrocolloid Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Irreversible Hydrocolloid Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhermack
  2. 6.1.1 Zhermack Company Information
  3. 6.1.2 Zhermack Business Overview
  4. 6.1.3 Zhermack Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhermack Irreversible Hydrocolloid Product Portfolio
  6. 6.1.5 Zhermack Recent Developments
  7. 6.2 Ultradent Products
  8. 6.2.1 Ultradent Products Company Information
  9. 6.2.2 Ultradent Products Business Overview
  10. 6.2.3 Ultradent Products Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ultradent Products Irreversible Hydrocolloid Product Portfolio
  12. 6.2.5 Ultradent Products Recent Developments
  13. 6.3 Septodont
  14. 6.3.1 Septodont Company Information
  15. 6.3.2 Septodont Business Overview
  16. 6.3.3 Septodont Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Septodont Irreversible Hydrocolloid Product Portfolio
  18. 6.3.5 Septodont Recent Developments
  19. 6.4 Monitex Industrial
  20. 6.4.1 Monitex Industrial Company Information
  21. 6.4.2 Monitex Industrial Business Overview
  22. 6.4.3 Monitex Industrial Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Monitex Industrial Irreversible Hydrocolloid Product Portfolio
  24. 6.4.5 Monitex Industrial Recent Developments
  25. 6.5 Lascod
  26. 6.5.1 Lascod Company Information
  27. 6.5.2 Lascod Business Overview
  28. 6.5.3 Lascod Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Lascod Irreversible Hydrocolloid Product Portfolio
  30. 6.5.5 Lascod Recent Developments
  31. 6.6 Kulzer
  32. 6.6.1 Kulzer Company Information
  33. 6.6.2 Kulzer Business Overview
  34. 6.6.3 Kulzer Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kulzer Irreversible Hydrocolloid Product Portfolio
  36. 6.6.5 Kulzer Recent Developments
  37. 6.7 Kerr
  38. 6.7.1 Kerr Company Information
  39. 6.7.2 Kerr Business Overview
  40. 6.7.3 Kerr Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kerr Irreversible Hydrocolloid Product Portfolio
  42. 6.7.5 Kerr Recent Developments
  43. 6.8 Ivoclar
  44. 6.8.1 Ivoclar Company Information
  45. 6.8.2 Ivoclar Business Overview
  46. 6.8.3 Ivoclar Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Ivoclar Irreversible Hydrocolloid Product Portfolio
  48. 6.8.5 Ivoclar Recent Developments
  49. 6.9 Hygedent
  50. 6.9.1 Hygedent Company Information
  51. 6.9.2 Hygedent Business Overview
  52. 6.9.3 Hygedent Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hygedent Irreversible Hydrocolloid Product Portfolio
  54. 6.9.5 Hygedent Recent Developments
  55. 6.10 Hager & Werken
  56. 6.10.1 Hager & Werken Company Information
  57. 6.10.2 Hager & Werken Business Overview
  58. 6.10.3 Hager & Werken Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hager & Werken Irreversible Hydrocolloid Product Portfolio
  60. 6.10.5 Hager & Werken Recent Developments
  61. 6.11 GC Corporation
  62. 6.11.1 GC Corporation Company Information
  63. 6.11.2 GC Corporation Business Overview
  64. 6.11.3 GC Corporation Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 GC Corporation Irreversible Hydrocolloid Product Portfolio
  66. 6.11.5 GC Corporation Recent Developments
  67. 6.12 Elsodent
  68. 6.12.1 Elsodent Company Information
  69. 6.12.2 Elsodent Business Overview
  70. 6.12.3 Elsodent Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Elsodent Irreversible Hydrocolloid Product Portfolio
  72. 6.12.5 Elsodent Recent Developments
  73. 6.13 DUX Dental
  74. 6.13.1 DUX Dental Company Information
  75. 6.13.2 DUX Dental Business Overview
  76. 6.13.3 DUX Dental Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 DUX Dental Irreversible Hydrocolloid Product Portfolio
  78. 6.13.5 DUX Dental Recent Developments
  79. 6.14 Dentsply Sirona
  80. 6.14.1 Dentsply Sirona Company Information
  81. 6.14.2 Dentsply Sirona Business Overview
  82. 6.14.3 Dentsply Sirona Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Dentsply Sirona Irreversible Hydrocolloid Product Portfolio
  84. 6.14.5 Dentsply Sirona Recent Developments
  85. 6.15 Dentamerica
  86. 6.15.1 Dentamerica Company Information
  87. 6.15.2 Dentamerica Business Overview
  88. 6.15.3 Dentamerica Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dentamerica Irreversible Hydrocolloid Product Portfolio
  90. 6.15.5 Dentamerica Recent Developments
  91. 6.16 Cavex
  92. 6.16.1 Cavex Company Information
  93. 6.16.2 Cavex Business Overview
  94. 6.16.3 Cavex Irreversible Hydrocolloid Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Cavex Irreversible Hydrocolloid Product Portfolio
  96. 6.16.5 Cavex Recent Developments
7 North America by Country
  1. 7.1 North America Irreversible Hydrocolloid Sales by Country
  2. 7.1.1 North America Irreversible Hydrocolloid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Irreversible Hydrocolloid Sales by Country (2021-2026)
  4. 7.1.3 North America Irreversible Hydrocolloid Sales Forecast by Country (2027-2032)
  5. 7.2 North America Irreversible Hydrocolloid Market Size by Country
  6. 7.2.1 North America Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Irreversible Hydrocolloid Market Size by Country (2021-2026)
  8. 7.2.3 North America Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Irreversible Hydrocolloid Sales by Country
  2. 8.1.1 Europe Irreversible Hydrocolloid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Irreversible Hydrocolloid Sales by Country (2021-2026)
  4. 8.1.3 Europe Irreversible Hydrocolloid Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Irreversible Hydrocolloid Market Size by Country
  6. 8.2.1 Europe Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Irreversible Hydrocolloid Market Size by Country (2021-2026)
  8. 8.2.3 Europe Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Irreversible Hydrocolloid Sales by Country
  2. 9.1.1 Asia-Pacific Irreversible Hydrocolloid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Irreversible Hydrocolloid Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Irreversible Hydrocolloid Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Irreversible Hydrocolloid Market Size by Country
  6. 9.2.1 Asia-Pacific Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Irreversible Hydrocolloid Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Irreversible Hydrocolloid Sales by Country
  2. 10.1.1 South America Irreversible Hydrocolloid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Irreversible Hydrocolloid Sales by Country (2021-2026)
  4. 10.1.3 South America Irreversible Hydrocolloid Sales Forecast by Country (2027-2032)
  5. 10.2 South America Irreversible Hydrocolloid Market Size by Country
  6. 10.2.1 South America Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Irreversible Hydrocolloid Market Size by Country (2021-2026)
  8. 10.2.3 South America Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Irreversible Hydrocolloid Sales by Country
  2. 11.1.1 Middle East and Africa Irreversible Hydrocolloid Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Irreversible Hydrocolloid Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Irreversible Hydrocolloid Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Irreversible Hydrocolloid Market Size by Country
  6. 11.2.1 Middle East and Africa Irreversible Hydrocolloid Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Irreversible Hydrocolloid Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Irreversible Hydrocolloid Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Irreversible Hydrocolloid Value Chain Analysis
  2. 12.1.1 Irreversible Hydrocolloid Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Irreversible Hydrocolloid Production Mode & Process
  7. 12.2 Irreversible Hydrocolloid Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Irreversible Hydrocolloid Distributors
  10. 12.2.3 Irreversible Hydrocolloid Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research